Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02086604
Brief Title: Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma

First Submitted : March 11, 2014
First Submitted that Met QC Criteria : March 12, 2014
First Posted : March 13, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : June 6, 2019
Last Update Posted : June 11, 2019